Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 290
Aptamer sequence: CCGTAATACGACTCACTATAGGGGAGCTCGGTACCGAATTCATGTTGGTAGTTGGCTTGTGTTCGTGTGTTAAGCTTTCAGAGAGGATCCTT
Target unique ID: P0C6X7
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_281 NG8 Protein R1AB_SARS 5.4 nM Buffer A: 50 mM Tris-HCl pH 6.8, 150 mM KCl, 20 mM imidazole, 0.05% Tween-20, 0.1% Triton X-100; Buffer B (Elution Buffer): 30 mL; 50 mM Tris-HCl pH 6.8, 150 mM KCl, 500 mM 19031435
Structure information of aptamer
Aptamer Sequence: CCGTAATACGACTCACTATAGGGGAGCTCGGTACCGAATTCATGTTGGTAGTTGGCTTGTGTTCGTGTGTTAAGCTTTCAGAGAGGATCCTT
The optimal secondary structure in dot-bracket notation: .(((...))).(((.((....(((((((.((((((((((.((.((((.....)))).)).))))).))))).))))))))).))).......
The centroid secondary structure in dot-bracket notation: .....................(((((((.((((((((((.((.((((.....)))).)).))))).))))).))))))).............
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_281 Description NG8
Aptamer chemistry DNA Length 92 nt
GC content 46.7% Molecular weight 28,730.15 Da
Molarity of 1 μg/μl solution 34.81 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted therapy
Sequence CCGTAATACGACTCACTATAGGGGAGCTCGGTACCGAATTCATGTTGGTAGTTGGCTTGTGTTCGTGTGTTAAGCTTTCAGAGAGGATCCTT
Applications Inhibit SARS-CoV replication
Target information
Type Detail Type Detail
Uniprot ID P0C6X7 Protein name Replicase polyprotein 1ab (pp1ab) (ORF1ab polyprotein) [Cleaved into: Host translation inhibitor nsp1 (Leader protein) (Non-structural protein 1) (nsp1); Non-structural protein 2 (nsp2) (p65 homolog); Papain-like protease nsp3 (PL-PRO) (EC 3.4.19.12) (EC 3.4.22.-) (Non-structural protein 3) (nsp3) (PL2-PRO); Non-structural protein 4 (nsp4); 3C-like proteinase nsp5 (3CL-PRO) (3CLp) (EC 3.4.22.69) (Main protease) (Mpro) (Non-structural protein 5) (nsp5) (SARS coronavirus main proteinase); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7); Non-structural protein 8 (nsp8); Non-structural protein 9 (nsp9); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL); RNA-directed RNA polymerase nsp12 (Pol) (RdRp) (EC 2.7.7.48) (Non-structural protein 12) (nsp12); Helicase nsp13 (Hel) (EC 3.6.4.12) (EC 3.6.4.13) (Non-structural protein 13) (nsp13); Proofreading exoribonuclease nsp14 (ExoN) (EC 2.1.1.-) (EC 3.1.13.-) (Guanine-N7 methyltransferase) (Non-structural protein 14) (nsp14); Uridylate-specific endoribonuclease nsp15 (EC 4.6.1.-) (NendoU) (Non-structural protein 15) (nsp15); 2'-O-methyltransferase nsp16 (EC 2.1.1.57) (Non-structural protein 16) (nsp16)]
Gene name(s) rep 1a-1b Organism Replicase polyprotein 1ab (pp1ab) (ORF1ab polyprotein) [Cleaved into: Host translation inhibitor nsp1 (Leader protein) (Non-structural protein 1) (nsp1); Non-structural protein 2 (nsp2) (p65 homolog); Papain-like protease nsp3 (PL-PRO) (EC 3.4.19.12) (EC 3.4.22.-) (Non-structural protein 3) (nsp3) (PL2-PRO); Non-structural protein 4 (nsp4); 3C-like proteinase nsp5 (3CL-PRO) (3CLp) (EC 3.4.22.69) (Main protease) (Mpro) (Non-structural protein 5) (nsp5) (SARS coronavirus main proteinase); Non-structural protein 6 (nsp6); Non-structural protein 7 (nsp7); Non-structural protein 8 (nsp8); Non-structural protein 9 (nsp9); Non-structural protein 10 (nsp10) (Growth factor-like peptide) (GFL); RNA-directed RNA polymerase nsp12 (Pol) (RdRp) (EC 2.7.7.48) (Non-structural protein 12) (nsp12); Helicase nsp13 (Hel) (EC 3.6.4.12) (EC 3.6.4.13) (Non-structural protein 13) (nsp13); Proofreading exoribonuclease nsp14 (ExoN) (EC 2.1.1.-) (EC 3.1.13.-) (Guanine-N7 methyltransferase) (Non-structural protein 14) (nsp14); Uridylate-specific endoribonuclease nsp15 (EC 4.6.1.-) (NendoU) (Non-structural protein 15) (nsp15); 2'-O-methyltransferase nsp16 (EC 2.1.1.57) (Non-structural protein 16) (nsp16)]
Status reviewed in uniprot database Length 7073
Mass 790,248 Activity regulation Inhibited by Remdesivir (GS-5734)
Involvement in disease N/A Catalytic activity Reaction=a ribonucleoside 5'-triphosphate + RNA(n) = diphosphate + RNA(n+1)
PDB ID(s)
1Q2W;1QZ8;1UJ1;1UK2;1UK3;1UK4;1UW7;1WOF;1YSY;1Z1I;1Z1J;2A5A;2A5I;2A5K;2ACF;2AHM;2ALV;2AMD;2AMQ;2BX3;2BX4;2C3S;2D2D;2DUC;2FAV;2FE8;2FYG;2G9T;2GA6;2GDT;2GRI;2GT7;2GT8;2GTB;2GX4;2GZ7;2GZ8;2GZ9;2H2Z;2H85;2HOB;2HSX;2IDY;2JZD;2JZE;2JZF;2K7X;2K87;2OP9;2OZK;2PWX;2Q6G;2QC2;2QCY;2QIQ;2RHB;2RNK;2V6N;2VJ1;2XYQ;2XYR;2XYV;2Z3C;2Z3D;2Z3E;2Z94;2Z9G;2Z9J;2Z9K;2Z9L;3D62;3E9S;3EBN;3R24;4TWW;4TWY;4WY3;4ZUH;5B6O;5C5N;5C5O;5C8S;5C8T;5C8U;5E6J;5F22;5N19;5N5O;5NFY;6JYT;6LNQ;6NUR;6NUS;6W79;6WCO;7LCP;7LCQ;
Function Multifunctional protein involved in the transcription and replication of viral RNAs.
Activity data
Interaction ID 290
Target type Protein
Target unique ID P0C6X7
Activity 5.4 nM
Binding Conditions/Buffer

Buffer A: 50 mM Tris-HCl pH 6.8, 150 mM KCl, 20 mM imidazole, 0.05% Tween-20, 0.1% Triton X-100; Buffer B (Elution Buffer): 30 mL; 50 mM Tris-HCl pH 6.8, 150 mM KCl, 500 mM

Assay

Effect of modified aptamers on the ATPase activity of SCV helicase

PubMed ID 19031435
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_1101 DNA CCGTAATACGACTCACTATAGGTATGTGACGCGCGTCAATCGCTGTCCTACCAAGCTTTGCAGAGAGGATCCTT 65.22%
Apta_1114 DNA TAATACGACTCACTATAGGGAGACCCAAGCCGATTTATTTTGTGCAGCTTTTGTTCCCTTTAGTGAGGGTTAATT 63.04%
Apta_953 DNA TCACCTCATACGACTCACTATAGCGGATCCGAGCCGGGGTGTTCTGTTGGCGGGGGCGGTGGGCGGGCTGGCTCGAACAAGCTTGC 57.61%
Apta_1102 DNA TACGACTCACTATAGGGATCCGTGACTGTACGGGCTCAGTCGTTACTTGAGAGTTGAATTCCCTTTAGTGAGGGTT 57.61%
Apta_140 DNA GGCAGGAAGACAAACACGATGGGGGGGTATGATTTGATGTGGTTGTTGCATGATCGTGGTCTGTGGTGCTGT 56.52%
Apta_950 DNA CACCTAATACGACTCACTATAGCGGATCCGAAGGGGGCGCGAGGTGTAAGGGTGTGGGGTGGTGGGTGGGCCTGGCTCGAACAAGCTTGC 55.43%
Apta_1103 DNA TACGACTCACTATAGGGATCCACCTATGGCAGATTGAGCCCAAGGGCTGTGCAGCGAATTCCCTTTAGTGAGGGTT 55.43%
Apta_550 DNA GGTAATACGACTCACTATAGGGAGATACCAGCTTATTCAATTTTACAGAACAACCAACGTCGCTCCGGGTACTTCTTCATCGAGATAGTAAGTGCAATCT 55.00%
Apta_887 DNA ACGCTCGGATGCCACTACAGGGGGGTGGTCCTGAGGGTGGTGTGGTTGGTTTGGTTTCCTCATGGACGTGCTGGTGAC 54.35%
Apta_1104 DNA TACGACTCACTATAGGGATCCCCCCGAGTGAAGAGCAGGACAGCGGGACAGCGTCGAATTCCCTTTAGTGAGGGTT 54.35%
Apta_1105 DNA TACGACTCACTATAGGGATCCAATGGCACAGCGCCTGGAACGTACTCTGTACCTGGAATTCCCTTTAGTGAGGGTT 54.35%
Apta_1106 DNA TACGACTCACTATAGGGATCCTTCGCATCCGGCACGATGGCTAGGACACCCCGATGAATTCCCTTTAGTGAGGGTT 54.35%
Apta_78 DNA ATCTCGACTAGTCATAGGGGGCGCGAACATACGCGGTTGGTGTGGTTGGCTGACAATACTCGT 53.26%
Apta_932 DNA ATACGACTCACTATTAGGGATGTCCACCATATAGATCGATTTAAGTCCCTCGTTATTAATGCTAGACTACTGACTACAA 53.26%
Apta_951 DNA CACCTAATACGACTCACTATAGCGGATCCGAGGGGGTAGCGGGTGGGCCGGTGGATGCGGGGCGCCGGCGCCTGGCTCGAACAAGCTTGC 53.26%
Apta_1119 DNA GGGAATGGATCCACATCTACGAATTCGGTTGTGAAGATTGGGAGCGTCGTGGCTACTTCACTGCAGACTTGACGAAGCTT 53.26%
Apta_704 DNA GTACGAATTCACGAGGTTGCCAGCGGGGCCAGCCACTTCTGTCAGTGAATTCCTGCTCGTATATCTACTCGCCCGCCTGCGAGCATGGAGTCGGATCCTCTA 52.94%
Apta_127 DNA GGTATTGAGGGTCGCATCCACTGGTCGTTGTTGTCTGTTGTCTGTTATGTTGTTTCGTGATGGCTCTAACTCTCCTCT 52.17%
Apta_128 DNA GGTATTGAGGGTCGCATCCCGTAGTGTGTTCTTATTCGTGTCTGTGTGTGTTCTGTCGGATGGCTCTAACTCTCCTCT 52.17%
Apta_247 DNA GGCTTTACACTTTATGCTTCCGTACCAGAACATATCGAGTGATCCTGGGAGGATAACAATTTCACACAGGAAACAG 52.17%